Showing 2941-2950 of 3315 results for "".
- Regeneron Boosts Production Capacity for COVID-19 Antibody Cocktail Via Deal With Rochehttps://modernod.com/news/regeneron-boosts-production-capacity-for-covid-19-antibody-cocktail-via-deal-with-roche/2478176/Regeneron Pharmaceuticals said that the overall capacity to produce REGN-COV2, a two-antibody cocktail against COVID-19, will increase by at least 3.5 times under a development and manufacturing collaboration with Roche. As part of the deal, Regeneron will market REGN-COV2 in the US, with Roche r
- How COVID-19 is Shaking Up Medical Education—For Goodhttps://modernod.com/news/how-covid-19-is-shaking-up-medical-education-for-good/2478168/With COVID-19 shows no signs of letting up soon, leaders at medical schools are adapting their plans for education in the fall to meet the new demands of the pandemic, according to a FierceHealthcare report. That means going digital in an unprecedented way—both in terms of classe
- Tom Frinzi Joins CorneaGen Board as Executive Chairhttps://modernod.com/news/tom-frinzi-joins-corneagen-board-as-executive-chair/2478159/CorneaGen announced that Tom Frinzi has joined the company’s board as executive chair. Mr. Frinzi brings more than 40 years of expertise in clinical-to-commercial transition and fostering next-level growth within small to mid-size private equity companies and Fortune 500 corporations. His
- TearClear Raises $22M in Series B Fundinghttps://modernod.com/news/tearclear-raises-22m-in-series-b-funding/2478158/TearClear announced it has raised $22 million in a Series B funding round. The company intends to use the funds to advance multiple clinical programs in development, with two lead candidates in glaucoma paving the way for future indications. Led by Chief Executive Officer Robert Dempsey, T
- Alcon Broadens US Availability of MARLO Digital Platformhttps://modernod.com/news/alcon-broadens-us-availability-of-marlo-digital-platform/2478153/Alcon announced broader US availability of its MARLO digital platform offered within independent OD practice. The platform allows patients to order, reorder and track their Alcon contact lens order online and have their lenses shipped right to their doorstep, while keeping the relationship and re
- Diagnostic Market Sees New Demand Due to Effects of COVID-19https://modernod.com/news/diagnostic-market-sees-new-demand-due-to-effects-of-covid-19/2478150/Increasing demand for telehealth and mobile applications due to the COVID-19 pandemic has led manufacturers to scramble to add functionality and accessibility to existing devices and protection apparatuses or create new devices, according to a Market Scope report. Regulatory bodies and re
- Ocugen Receives Fourth FDA Orphan Drug Designation for Gene Therapy for the Treatment of Another Inherited Retinal Diseasehttps://modernod.com/news/ocugen-receives-fourth-fda-orphan-drug-designation-for-gene-therapy-for-the-treatment-of-another-inherited-retinal-disease/2478149/Ocugen announced the FDA granted the fourth Orphan Drug Designation (ODD) for OCU400 in the treatment of PDE6B gene mutation-associated retinal diseases. Retinitis Pigmentosa (RP) caused by PDE6B mutation is an inherited retinal dystrophy that leads to blindness by midlife and
- CooperVision Acquires GP Specialists, Expanding Specialty EyeCare Business and Ortho-K Optionshttps://modernod.com/news/coopervision-acquires-gp-specialists-expanding-specialty-eyecare-business-and-ortho-k-options/2478137/CooperVision has acquired C&E GP Specialists, a customized orthokeratology contact lens manufacturer and distributor. The move expands CooperVision’s Specialty eye care business. Terms of the deal were not disclosed. “CooperVision is committed to providing eye care professionals
- Vitamin B3 Shows Promise for Glaucoma Patients in Clinical Trialhttps://modernod.com/news/vitamin-b3-shows-promise-for-glaucoma-patients-in-clinical-trial/2478100/A clinical trial led by the Center for Eye Research Australia has shown that vitamin B3 (nicotinamide) could play an important role in protecting against nerve cell damage that leads to blindness in glaucoma, according to a
- Senate GOP Outlines Next Coronavirus Relief Bill as Deadline for Enhanced Unemployment Benefits Nearshttps://modernod.com/news/senate-gop-outlines-next-coronavirus-relief-bill-as-deadline-for-enhanced-unemployment-benefits-nears/2478090/Senate Republicans outlined their fourth phase of federal coronavirus response efforts, rolling out their legislative package as enhanced unemployment benefits are beginning to expire for millions of Americans who are out of work due to the coronavirus pandemic, accordin